229 related articles for article (PubMed ID: 25371446)
1. Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.
Torres-Mejía G; Royer R; Llacuachaqui M; Akbari MR; Giuliano AR; Martínez-Matsushita L; Angeles-Llerenas A; Ortega-Olvera C; Ziv E; Lazcano-Ponce E; Phelan CM; Narod SA
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):498-505. PubMed ID: 25371446
[TBL] [Abstract][Full Text] [Related]
2. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
Villarreal-Garza C; Alvarez-Gómez RM; Pérez-Plasencia C; Herrera LA; Herzog J; Castillo D; Mohar A; Castro C; Gallardo LN; Gallardo D; Santibáñez M; Blazer KR; Weitzel JN
Cancer; 2015 Feb; 121(3):372-8. PubMed ID: 25236687
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Kwan E; Jack E; Vesprini DJ; Kuperstein G; Abrahamson JL; Fan I; Wong B; Narod SA
Am J Hum Genet; 2001 Mar; 68(3):700-10. PubMed ID: 11179017
[TBL] [Abstract][Full Text] [Related]
4. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A
J Natl Cancer Inst; 2001 Aug; 93(16):1215-23. PubMed ID: 11504767
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation.
Vaidyanathan K; Lakhotia S; Ravishankar HM; Tabassum U; Mukherjee G; Somasundaram K
J Biosci; 2009 Sep; 34(3):415-22. PubMed ID: 19805903
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study.
de Sanjosé S; Léoné M; Bérez V; Izquierdo A; Font R; Brunet JM; Louat T; Vilardell L; Borras J; Viladiu P; Bosch FX; Lenoir GM; Sinilnikova OM
Int J Cancer; 2003 Sep; 106(4):588-593. PubMed ID: 12845657
[TBL] [Abstract][Full Text] [Related]
8. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
9. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
[TBL] [Abstract][Full Text] [Related]
10. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients.
Vidal-Millán S; Taja-Chayeb L; Gutiérrez-Hernández O; Ramírez Ugalde MT; Robles-Vidal C; Bargallo-Rocha E; Mohar-Betancourt A; Dueñas-González A
Eur J Gynaecol Oncol; 2009; 30(5):527-30. PubMed ID: 19899408
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.
Claus EB; Petruzella S; Matloff E; Carter D
JAMA; 2005 Feb; 293(8):964-9. PubMed ID: 15728167
[TBL] [Abstract][Full Text] [Related]
13. Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history.
Kang PC; Phuah SY; Sivanandan K; Kang IN; Thirthagiri E; Liu JJ; Hassan N; Yoon SY; Thong MK; Hui M; Hartman M; Yip CH; Mohd Taib NA; Teo SH
Breast Cancer Res Treat; 2014 Apr; 144(3):635-42. PubMed ID: 24578176
[TBL] [Abstract][Full Text] [Related]
14. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
Antoniou A; Pharoah PD; Narod S; Risch HA; Eyfjord JE; Hopper JL; Loman N; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles DM; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi OP; Thompson D; Evans C; Peto J; Lalloo F; Evans DG; Easton DF
Am J Hum Genet; 2003 May; 72(5):1117-30. PubMed ID: 12677558
[TBL] [Abstract][Full Text] [Related]
15. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
16. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases.
Malone KE; Daling JR; Neal C; Suter NM; O'Brien C; Cushing-Haugen K; Jonasdottir TJ; Thompson JD; Ostrander EA
Cancer; 2000 Mar; 88(6):1393-402. PubMed ID: 10717622
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.
Capalbo C; Ricevuto E; Vestri A; Ristori E; Sidoni T; Buffone O; Adamo B; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G
Ann Oncol; 2006 Jun; 17 Suppl 7():vii34-40. PubMed ID: 16760289
[TBL] [Abstract][Full Text] [Related]
18. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
Peto J; Collins N; Barfoot R; Seal S; Warren W; Rahman N; Easton DF; Evans C; Deacon J; Stratton MR
J Natl Cancer Inst; 1999 Jun; 91(11):943-9. PubMed ID: 10359546
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling.
Palmieri G; Palomba G; Cossu A; Pisano M; Dedola MF; Sarobba MG; Farris A; Olmeo N; Contu A; Pasca A; Satta MP; Persico I; Carboni AA; Cossu-Rocca P; Contini M; Mangion J; Stratton MR; Tanda F
Ann Oncol; 2002 Dec; 13(12):1899-907. PubMed ID: 12453858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
